Abstract
The aim of the study was to examine whether endothelin-1 (ET-1) injected into dorsolateral periaqueductal gray (PAG) area of mice produces antinociception. ET-1, from 1 to 4 pmol/mouse, induced antinociceptive effect in a dose-dependent manner. This antinociceptive effect was prevented by NMDA receptor antagonists (2-APV and MK-801) injected in the same area (2-APV) or by intraperitoneal route (MK-801). CNQX, a non-NMDA receptor antagonist, did not inhibit the ET-1 effects. Prazosin, an alpha 1-adrenergic blocking agent, also prevented the ET-1 antinociceptive effect. We suggest that the activation of NMDA glutamatergic receptors in the PAG area may be a necessary step for ET-1 induced antinociception.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
2-Amino-5-phosphonovalerate / pharmacology
-
6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
-
Adrenergic alpha-Antagonists / pharmacology
-
Analgesics / pharmacology*
-
Animals
-
Dizocilpine Maleate / pharmacology
-
Dose-Response Relationship, Drug
-
Endothelin-1 / pharmacology*
-
Excitatory Amino Acid Antagonists / pharmacology
-
Male
-
Mice
-
Mice, Inbred Strains
-
Periaqueductal Gray / drug effects*
-
Prazosin / pharmacology
-
Receptors, Glutamate / drug effects*
Substances
-
Adrenergic alpha-Antagonists
-
Analgesics
-
Endothelin-1
-
Excitatory Amino Acid Antagonists
-
Receptors, Glutamate
-
Dizocilpine Maleate
-
6-Cyano-7-nitroquinoxaline-2,3-dione
-
2-Amino-5-phosphonovalerate
-
Prazosin